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endovascular stent grafting of thoracic aorta
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Objective: Thrombosis is common in aneurysms immediately after stent-grafting, because of exclusion from systemic
blood flow. We studied changes in blood coagulation and the fibrinolytic system in patients with thoracic aortic aneurysm
or dissection after stent-grafting to examine risk for consumption coagulopathy.
Methods: Thirty-one thoracic aortic aneurysms were treated with stent-grafting (aneurysm group), and 29 aortic
dissections were treated with entry closure with stent-grafting (dissection group). The stent-graft was constructed from
a self-expanding Z stent and thin-walled woven polyester fabric. Platelet count, fibrinogen, antithrombin III (AT III),
and thrombin-AT III complex were assayed as markers of coagulation. Plasminogen, 2-plasmin inhibitor, 2-plasmin
inhibitor-plasmin complex, fibrin degradation products fragment E (FDP-E), and fibrin degradation products D-dimer
were monitored as markers of fibrinolysis. Blood samples were collected before surgery and on postoperative days 1, 3,
7, and 14.
Results: In both groups platelet count significantly decreased on postoperative days 1 and 3, and increased on
postoperative day 14. AT III significantly decreased on postoperative day 1, but recovered after postoperative day 7.
FDP-E significantly increased on postoperative day 1 in both groups. There was significant correlation of aneurysm
diameter with 2-plasmin inhibitor-plasmin complex, fibrin degradation products, and D-dimer in the dissection group
on postoperative day 1.
Conclusions: Activation of coagulation and fibrinolysis was observed after stent-grafting to treat thoracic aortic aneurysm
and aortic dissection. However, no patients exhibited consumption coagulopathy postoperatively. Therefore we believe
there is little risk for consumption coagulopathy after stent-grafting. (J Vasc Surg 2003;37:1213-8.)
The advantages of endovascular grafting for treatment
of thoracic aortic aneurysm and aortic dissection, compared
with conventional open surgery, were previously reported
by the Stanford group.1-3 However, side effects from the
procedure were not sufficiently examined. Mialhe et al4
reported that fever occurred in 57% of patients who under-
went endovascular repair of abdominal aortic aneurysm,
and blood coagulation disorders developed postoperatively
in 10% of patients. Norgen et al5 observed inflammatory
response and decreased platelet count after endovascular
grafting of aortic aneurysm. Thrombosis is commonly ob-
served in aneurysms immediately after stent-grafting, be-
cause of exclusion from systemic blood flow.
On the other hand, enhancement of coagulation and
depression of fibrinolysis occurring within 3 days after open
surgery to treat abdominal aortic aneurysm (AAA) with an
artificial graft has been reported.6 Similarly, inhibition of
systemic fibrinolysis and marked thrombin generation have
occurred after repair of ruptured AAA, and similar changes
have been noted in nonruptured AAA.7 Brithers et al8
found systemic fibrinolysis, detected at thrombelastogra-
phy, in 25% of patients who had undergone AAA repair.8
We expected more marked activation of coagulative and
fibrinolytic systems after endovascular grafting than after
open surgery, because blood products such as platelets and
fibrinogen are consumed by generation of thrombus in an
aneurysmal sac or false lumen.
To date there have been two reports of consumption
coagulopathy after stent-grafting: Ohara et al9 reported a
case in which a patient with AAA died of adult respiratory
distress syndrome and disseminated intravascular coagula-
tion (DIC) after stent-grafting, and Cross et al10 reported
fatal consumptive coagulopathy after stent-grafting in a
patient with AAA. If bleeding is prolonged, consumption
coagulopathy can cause serious complications such as DIC
and multiple organ failure. Differences in hemodynamics
after stent-grafting have been observed between thoracic
aortic aneurysm and aortic dissection. A thrombus that
forms in the aneurysmal sac of a thoracic aortic aneurysm
after stent-grafting is separated from systemic blood flow,
whereas a thrombus in aortic dissection remains in contact
with the systemic blood flow through the reentry. This
suggests that activation of coagulation and fibrinolysis is
more likely after stent-grafting to treat aortic dissection
than after stent-grafting to treat aortic aneurysm.
We studied changes in blood coagulation and the fi-
brinolytic system in patients with thoracic aortic aneurysm
and aortic dissection treated with stent-grafting.
METHODS
Patients. Thirty-one patients (25 men, 6 women;
mean age, 69.9 years) with thoracic aortic aneurysm under-
went stent-grafting (aneurysm group), and 29 patients (27
men, 2 women; mean age, 54.4 years) with aortic dissection
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(double-barrel type) underwent entry closure with stent-
grafting (dissection group). All aortic dissections were
chronic (Stanford type B), without preoperative consump-
tion coagulopathy. The results of elective stent-grafting
alone are reported here; emergency cases were not included
in the study. No patient in either group had a history of liver
disease or was taking oral anticoagulation therapy before
the operation. Anticoagulant, eg, nalmostat mesilate or
gabexate mesilate (proteinase inhibitors often used to treat
DIC), was not administered during the postoperative
course. In all cases, before stent-grafting informed consent
was obtained according to guidelines of the Ethics Com-
mittee of Tokyo Medical University.
Stent-graft. The stent-graft was constructed from a
self-expanding Gianturco Z stent (Cook, Bloomington,
Ind) and thin-walled woven polyester fabric (Ube Indus-
tries, Ube, Japan). The femoral artery was exposed with the
patient under general anesthesia. Activated coagulation
time was maintained at more than 200 seconds with intra-
venous administration of 50 U/kg of heparin before sheath
insertion. A guide wire, 400 cm long and 0.032 inches in
diameter, was introduced through the right brachial artery
and down to the abdominal aorta. The distal end of the
guide wire was caught with a snare catheter (Microvena,
White Bear Lake, Minn) and picked up at the femoral
artery. An 18F or 20F sheath (Cook) was introduced
transfemorally over the guide wire with the tug-of-wire
technique.11 Excluded aneurysm was confirmed with digi-
tal subtraction angiography immediately after the opera-
tion and with computed tomography (CT) on postopera-
tive day 10.
Blood samples. Platelet count (normal range, 140-
340  109/L), fibrinogen (normal range, 2-4 g/L), anti-
thrombin III (AT III; normal, 70%), and thrombin-AT
III complex (normal range, 0-2.0 ng/mL) were assayed as
markers of coagulation. Plasminogen (normal range, 80%-
120%), 2-plasmin inhibitor (normal range, 80%-120%),
2-plasmin inhibitor-plasmin complex (normal range,
0-0.8 mg/mL), FDP-E (normal, 100 ng/mL), and fi-
brin degradation products D-dimer (normal, 0.8 mg/
mL) were assayed as markers of fibrinolysis. Samples were
collected before the operation and on days 1, 3, 7, and 14
postoperatively.
Statistics. Statistical analysis was performed with Stat-
View software (SAS Institute, Cary, NC). Differences be-
tween preoperative and postoperative values (postoperative
days 1, 3, 7, and 14) were assessed with Wilcoxon signed-
rank test and the Holm method. The Mann-Whitney U test
was used to compare groups of patients. Because the data
were not normally distributed, the Spearman rank test was
used to assess the correlation between aneurysm diameter
and various values on postoperative day 1. All values are
expressed as means  SD. P  .05 was considered statisti-
cally significant.
RESULTS
Surgical data (Table I). Mean aneurysm diameter
was 58  16 mm in the aneurysm group and 54  15 mm
in the dissection group. No significant difference was ob-
served between the two groups. Stent-grafting was success-
fully performed in all patients. In the aneurysm group,
aneurysms were completely excluded in all patients. In the
dissection group, partial thrombus in the false lumen was
observed on the postoperative CT scan. Postoperative
change in aneurysm diameter was not noted in either
group, and no graft infection, thromboembolism, or para-
plegia developed in any patient. Operation time was signif-
icantly longer in the aneurysm group (250  74 minutes)
than in the dissection group (195  61 minutes) (P 
.005). Blood loss during stent-graft repair was significantly
higher in the aneurysm group (457 373 mL) than in the
dissection group (168  183 mL) (P  .05).
Changes in coagulation (Table II). Platelet count
decreased significantly in both groups on postoperative
days 1 and 3 (P  .01), but returned to the preoperative
value on postoperative day 7. Platelet count in both groups
on postoperative day 14 was significantly higher than the
preoperative value (P  .01). In both groups, fibrinogen
increased postoperatively, with significant increase after
postoperative day 3 (P  .01). In contrast, AT III level
decreased significantly in both groups on postoperative day
1 (P  .01) and recovered after postoperative day 7.
Thrombin-AT III complex in both groups increased signif-
icantly on postoperative day 1 (P .01) and recovered after
postoperative day 7.
Changes in fibrinolytic system (Table III). Plas-
minogen decreased significantly in both groups on postop-
erative day 1 (P  .01), but increased after postoperative
day 7, with a significant increase on postoperative day 14
(P  .01). In both groups, 2-plasmin inhibitor decreased
Table I. Patient and surgical data
Aneurysm group
(n  31)
Dissection group
(n  29) P
Age (y) 69.9  7.6 54.4  13.7 .0001
Sex (% men) 80.6 93.1 NS
Diameter of aneurysm (mm) 58  16 54  15 NS
Operation time (min) 250  74 195  61 .005
Bleeding volume (mL) 457  373 168  183 .05
Blood transfusion (mL) 108  197 66  156 NS
Values are given as mean  SD or percentage of patients.
NS, Not significant.
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significantly on postoperative day 1 (P  .01) and recov-
ered to the preoperative value by postoperative day 3.
2-Plasmin inhibitor-plasmin complex increased signifi-
cantly on postoperative day 1 in both groups (P .01) and
on postoperative day 14 in the aneurysm group (P .001).
FDP-E increased significantly on postoperative day 1 in
both groups (P .01). In the dissection group, no further
significant increase in FDP-E was observed after postoper-
ative day 3; however, in the aneurysm group FDP-E con-
tinued to increase after postoperative day 3 (P  .01).
D-Dimer increased significantly in both groups on postop-
erative day 1 (P  .01), and no significant increase was
observed after postoperative day 3.
Differences in coagulation and fibrinolytic system
between groups (Figs 1 and 2). There were no signifi-
cant differences in platelet count, fibrinogen, AT-III, plas-
minogen, 2-plasmin inhibitor, FDP-E, or D-dimer be-
tween groups. A significant difference in thrombin-AT III
complex level was observed on postoperative day 1 (P 
.005).
On postoperative day 1 the aneurysm group had signif-
icantly lower levels of 2-plasmin inhibitor-plasmin com-
plex compared with the dissection group (P  .005).
Correlation of aneurysm diameter with coagulation
and fibrinolytic system (Table IV). Aneurysm diameter
correlated significantly with 2-plasmin inhibitor-plasmin
complex, FDP, and D-dimer in the dissection group on
postoperative day 1. No other significant correlations were
observed.
DISCUSSION
Recent advances in endovascular therapy have been
remarkable. In particular, developments in stent-graft tech-
nology for treatment of aortic aneurysm or dissection have
made it an intriguing option. Conventional open surgery to
treat thoracic aortic aneurysm or dissection is an invasive
cardiopulmonary bypass procedure. In contrast, stent-
grafting is a minimally invasive procedure with short oper-
ation time and little blood loss. However, few reports have
addressed the complications associated with stent-grafting,
including fever and postoperative decrease in platelet
count,4,5 as well as fatal sequelae such as coagulative disor-
ders.9,10
Hollier et al12 reported nonresective therapy for AAA
in patients at high-risk. In their study, abdominal aneurysm
was excluded by ligating the proximal and distal sides of the
Table II. Coagulation data
Group Preoperative value
Postoperative day
1 3 7 14
Platelets (109/L) Aneurysm 22.4  9.2 15.6  8.5† 15.3  7.5† 22.7  6.6 32.5  9.4†
Dissection 21.3  5.0 14.9  3.8† 15.4  5.8† 23.4  6.8 33.5  9.6†
Fibrinogen (g/L) Aneurysm 342  122 332  93 562  183† 560  172† 472  108†
Dissection 339  123 365  146 528  165† 585  197† 574  177†
AT-III (%) Aneurysm 98  17 80  11† 84  15† 97  14 99  12
Dissection 100  13 91  10* 95  16 100  12 103  14
TAT (ng/ml) Aneurysm 7.5  7.4 21.1  17.6† 19.9  24.1† 12.4  14.0 11.4  15.1
Dissection 7.3  5.3 36.2  18.6† 18.6  16.4† 9.2  4.5 9.1  3.9
Values are given as mean  SD.
AT III, Antithrombin III; TAT, thrombin-antithrombin III complex.
*P  .05 vs preoperative value.
†P  .01 vs preoperative value.
Table III. Fibrinolytic data
Group
Preoperative
value
Postoperative day
1 3 7 14
PLG (%) Aneurysm 98  19 81  13† 87  17† 110  21† 111  17†
Dissection 100  25 85  19* 85  20† 104  21* 115  25†
2-PI (%) Aneurysm 93  12 81  15
† 98  18 104  16* 95  14
Dissection 98  13 82  20† 98  20 106  17 98  27
PIC (g/mL) Aneurysm 1.1  0.5 2.0  1.6† 2.1  1.7† 2.3  1.4† 2.4  2.7†
Dissection 2.0  2.0 6.1  5.5† 3.7  4.5† 3.3  3.8† 3.1  1.9
FDP-E (ng/mL) Aneurysm 182  136 596  391† 426  361† 415  287† 416  313†
Dissection 397  69 1399  1505† 694  616* 572  445* 499  318
DD (g/mL) Aneurysm 5.6  13.0 10.5  8.1† 8.9  10.1 7.3  4.8 7.2  5.3
Dissection 6.8  10.8 16.8  14.1† 10.9  8.1 9.7  5.8 8.7  5.2
Values are given as mean  SD.
PLG, Plasminogen; PI, plasmin inhibitor; PIC, 2-plasmin inhibitor–plasmin complex; FDP-E, fibrin degradation products fragment E; DD, D-dimer.
*P  .05 vs preoperative value.
†P  .01 vs preoperative value.
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aneurysm with an axillobifemoral bypass. Schwartz et al13
reported the possibility of DIC as a complication of this
type of nonresective therapy for aortic aneurysm. Therefore
we considered the possibility of consumption coagulopathy
due to thrombus formation in the aneurysm sac after stent-
grafting. We checked for a decrease in AT III and an
increase in thrombin-AT III complex, because these are
involved in the last steps of the transformation of fibrinogen
to fibrin. Plasmin is an important element of the fibrinolytic
system, but it is difficult to measure plasmin because of its
short period of activity. Therefore we measured 2-plasmin
inhibitor, an inhibitor of coagulation, and 2-plasmin in-
hibitor-plasmin complex, a complex of plasmin and 2-
plasmin inhibitor. We found acceleration of coagulation
and the fibrinolytic system on postoperative day 1; how-
ever, all factors began to return to preoperative levels on
postoperative day 3. Also, none of our patients exhibited
consumption coagulopathy preoperatively or postopera-
tively.
Ohara et al9 reported a patient with AAA and severe
liver cirrhosis who died of ARDS and DIC after stent-
grafting. In that case, DIC resulted from acute consump-
tion of coagulation factors, and ARDS resulted from high
levels of cytokines such as interleukin-6 and tumor necrosis
factor-; these cytokines were not inactivated, because of
severe liver dysfunction. Preoperative platelet count in that
case was 55  109/L, suggesting that the likelihood of
consumption coagulopathy is higher in patients with a
preoperative coagulation disorder. Cross et al10 reported
development of consumptive coagulopathy after stent-
grafting. They found that the endothelium was stimulated
by endovascular devices and speculated that the microem-
bolism, which occurred as petechial haemorrhage involving
the skin and the gastric and vaginal mucosae, caused con-
sumption coagulopathy by activating coagulative cascades.
In that case no preoperative coagulation disorder was
found, but the stent- grafting procedure was technically
difficult and time-consuming because of the small, tortuous
iliofemoral vessels. Thus it appears that the likelihood of
consumptive coagulopathy is higher in cases in which there
is a preoperative coagulative disorder or stent-grafting is
technically difficult.
The changes we observed in platelet count were of
great interest. Platelet count decreased on postoperative
day 1 but recovered by postoperative day 7. On postoper-
ative day 14 the count was higher than the preoperative
value. Such biphasic changes have been reported after
replacement of an infrarenal AAA with a vascular prosthesis.
Utoh et al14 reported that the time to peak platelet count
varied with artificial blood vessel type. The stent-graft in
our study was constructed from a Z stent and thin-walled
Fig 1. Differences between preoperative and postoperative coagulation indices. 	, Difference between preoperative
value and each postoperative value. *P  .05, **P  .01 for comparison of changes between aneurysm group and
dissection group. POD, Postoperative day; AT-III, antithrombin III; TAT, thrombin-antithrombin III complex.
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woven polyester fabric. Further study is required to clarify
the effects of various vascular prostheses on platelet count.
There were significantly larger increases in throm-
bin-AT III complex and 2-plasmin inhibitor-plasmin
complex in the dissection group than in the aneurysm
group on postoperative day 1. We considered the possible
causes of these differences. There was a clear difference in
purpose of performing stent-grafting between the two
groups, ie, to exclude aneurysm and prevent rupture of
aneurysm in the aneurysm group and to close the intimal
tear and decompress the false lumen in the dissection
group. Therefore retrograde blood flow to the false lumen
occurred through reentry in the dissection group, whereas
blood flow in the aneurysm group was antegrade. The
difference in hemodynamics on the various postoperative
days may have produced the differences in results between
the aneurysm group and the dissection group, but other
factors may also be involved.
Table IV. Correlation of aneurysm diameter with
coagulation and fibrinolytic data
r
Aneurysm
group
Dissection
group
Platelets 0.22 0.06
Fibrinogen 
0.04 
0.12
AT-III 0.05 
0.38
TAT 
0.12 0.13
Plasminogen 
0.16 
0.23
2-PI 
0.05 
0.35
PIC 0.18 0.62*
FDP-E 0.17 0.69*
DD 0.29 0.57*
AT-III, Antithrombin III; TAT, thrombin–antithrombin III complex; PI,
2-plasmin inhibitor; PIC, 2-plasmin inhibitor–plasmin complex; FDP-E,
fibrin degradation products fragment E; DD, D-dimer.
*P  .01; significant correlation.
Fig 2. Differences between preoperative and postoperative values in fibrinolytic system. 	, Difference between
preoperative value and each postoperative value. *P  .05, **P  .01 for comparison of changes between aneurysm
group and dissection group. PI, 2-Plasmin inhibitor; PIC, 2-plasmin inhibitor-plasmin complex; FDP-E, fibrin
degradation products E fragment.
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In the dissection group we found significant correlation
of aneurysm diameter with 2-plasmin inhibitor-plasmin
complex, FDP-E, and D-dimer on postoperative day 1. In
patients with a large false lumen, 2-plasmin inhibitor-
plasmin complex, FDP-E, and D-dimer increased on post-
operative day 1, and a hyperfibrinolytic state was observed.
A large false lumen results from torrential flow through a
large primary tear into the false lumen. In cases with a large
false lumen after stent-grafting, there is considerable retro-
grade blood flow to the false lumen and intense turbulent
blood flow. It is important to measure coagulation and
fibrinolytic factors in patients with aortic dissection with a
large false lumen, because these patients are in a hyperfi-
brinolytic state. We could not find a significant correlation
between aneurysm diameter and coagulation factors.
Therefore we are not certain whether the hyperfibrinolytic
state causes DIC. We did not find a correlation in the
aneurysm group between aneurysm diameter and coagula-
tion or fibrinolytic factors on postoperative day 1. This may
have resulted from cutting off the thrombus in the aneu-
rysm from the systemic blood flow and preventing throm-
bus formation in the venous blood. Therefore the possibil-
ity of consumption coagulopathy is not increased, even if
stent-grafting is performed to treat large true aneurysms.
Comparison with conventional surgery is required to
further clarify the changes in the coagulation and fibrino-
lytic factors after stent-grafting to treat thoracic aortic
aneurysm. However, in conventional open surgery, extra-
corporeal circulation and high doses of heparin are required
for continuous blood flow to the main organs. In addition,
blood loss increases, sometimes resulting in homogeneous
blood transfusion. Thus comparison with stent-grafting
may be difficult, because other factors influence coagula-
tion and fibrinolysis.
Because the present study is a negative study, we must
consider the risk for type II error. We performed stent-
grafting in more than 180 patients with thoracic aneurysm
and more than 80 patients with aortic dissection, and
consumptive coagulopathy did not develop in any patients.
Therefore we were unable to determine the rate of occur-
rence of this side effect. This qualifies as a limitation of the
study. Accordingly, we will be on the lookout for future
case reports of consumptive coagulopathy as a side effect of
stent-grafting.
In conclusion, activation of coagulation and fibrinolysis
was observed after stent-grafting to treat thoracic aortic
aneurysm and aortic dissection. However, none of our
patients had consumption coagulopathy postoperatively.
Therefore we believe that there is little risk for consumption
coagulopathy after stent-grafting. We recommend mea-
surement of the markers of coagulation and the fibrinolytic
system in patients with aortic dissection with a large false
lumen, because fibrinolysis is associated with false lumen
diameter.
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